YES BANK LTD. · Q2 FY27 · THE VERDICT

Growth Masks the Margin Stall

YES Bank posted 17.1% revenue growth and beat loan-growth guidance, but net profit decelerated sharply quarter-on-quarter (QoQ +1.1%) as NIM compressed 12–14 basis points from FCNR mobilization. The real question: can management deliver the margin recovery roadmap, or is the capital overhang a bigger constraint?

Q2 FY27 results YESBANKYES BANK LTD.23 Oct 2026 · 6 min read

PAT growth YoY

63.2%

₹1084 Cr vs ₹664 Cr prior year

PAT growth QoQ

1.1%

₹1084 Cr vs ₹1072 Cr prior quarter

Revenue YoY

+17.1%

₹8649.5 Cr organic growth

NIM compression

12–14 bps

FCNR-driven; 2.6% current vs. 3%+ target

The headline is a strong YoY quarter—revenue +17.1%, PAT +63.2%—but the meat of the story is buried in the sequential line. Net profit grew just 1.1% quarter-on-quarter despite revenue up 7.4%. That gap is NIM compression: the 12–14 basis points decline to 2.6% from FCNR(B) mobilization (₹18.5k Cr) and associated liquidity costs. Loan growth at 17.1% YoY beat guidance and delivers on the FY27 loan-growth target, but sequential momentum stalled because margin headwinds outpaced top-line expansion.

Where the profit growth came from

Revenue expansion is real and broad-based. Net interest income jumped 22.7% YoY to ₹2,822 Cr, anchored by a 23.7% advance growth (ex-FCTN normalized to 17.6%). Non-interest income (core fees) rose 15.5% YoY to ₹477 Cr. Loan growth fanned across retail (+35% YoY), commercial banking (+20.2%), and corporate (+31.4%). Asset quality improved: gross NPA at 1.2% (down from 1.3% prior year), net NPA at 0.2%. Slippages held steady at 1.3% of advances quarter-on-quarter, confirming stabilization.

But NIM compression ate most of the NII upside. The bank took in ₹18.5k Cr of FCNR(B) deposits during Q2—a liquidity management tool to fund growth without straining the domestic deposit base. The cost of these deposits and the deployment friction (short-term investments, Nostro placements) depressed the margin. This is not a flaw in strategy; it is a planned trade-off. Management flagged it on the call and laid out the reversal mechanics: RIDF rundown (₹8,000 Cr budgeted H2, split ₹4,500 Cr Q3 and ₹3,500 Cr Q4), a repo rate hike benefit (25 basis points assumed post-October 2026), and deposit repricing beginning November onwards.

The sequential moderation of approximately 12 to 14 basis points was largely attributable to the FCNR(B) mobilization and the associated liquidity and deployment profile.

Q2 FY27 Drivers, ₹ Cr

Sequential revenue +₹1,269 Cr offset by NIM compression (~₹372 Cr estimated impact from 12bps on ₹3.1L Cr advances). Illustrative; actual mix includes non-interest income and operating leverage.

Management claims vs. what holds up

Net profit INR 1,080 Cr, +65% YoY

Net profit ₹1,084.1 Cr delivered, +63.2% YoY

Slightly overstated (2.8pp difference)

Advances grew 23.7% YoY; normalized ex-FCTN 17.6%

Reported 23.7% YoY advance growth confirmed; normalization credible given ₹15k Cr FCNR + IBU funding

Supported

NIM 2.6% with 12–14bps moderation from FCNR

NIM compression documented; traced to FCNR(B) ₹18.5k Cr mobilization and liquidity costs

Supported

Loan growth 15–17% range; delivering on FY27 guidance

Delivered 17.1% YoY growth, at upper band of guidance; exceeding expectation

Supported (beat by 100–200bps)

Gross NPA 1.2%, Net NPA 0.2%, both improved YoY

Asset quality metrics stable and improving; slippages 1.3% of advances stable Q-o-Q

Supported

ROA aspiration 1% on track; core ROA improving

Q2 ROA 0.9%; core ROA trending toward 1% target. Non-core items (Security Receipts, tax) noise

Supported; on path

What changed on this call

Three strategic shifts emerged. First, the AT-1 Supreme Court judgment materialized as a pro forma capital constraint: the write-down of ₹8.4k Cr reduces CET-1 by ~240 basis points. Pro forma CET-1 stands at 11.4% (or 13.7% Overall Tier 1), above regulatory minimum but below peer comfort (12%+). Capital raise timing deferred pending assessment—a new, unresolved overhang not present in the Q1 guidance. Second, loan growth acceleration: the bank beat its 15–17% average growth target at 17.1% YoY, signalling stronger market share gains and execution in retail (+35%), commercial (+20%), and corporate (+31%) segments. This is a positive delta from prior guidance. Third, the margin recovery roadmap was crystallized with specifics: ₹8,000 Cr RIDF rundown H2 (split Q3/Q4), a repo rate hike benefit (25bps post-October), and deposit repricing beginning November. These are concrete lever identifications, not vague promises.

The debate

Bull case: YES Bank is executing on growth (17.1% beats 15–17% guidance), delivering loan volume across all segments, improving asset quality, and demonstrating operational leverage (Cost-to-Income 290bps better YoY). Loan growth at 17.1% YoY outpaces industry; deposits scaling (+19.5% YoY), with retail mix improving (58.8% of total, +20.9% YoY). The bank is crossing ₹5 lakh Cr assets, ₹3.5 lakh Cr deposits, and ₹3 lakh Cr advances—scale inflection points. One Bank cross-sell and SMBC synergies are beginning to generate referral traction. ROA is progressing toward the 1% FY27 target (currently 0.9%). Capital, while tight at 11.4% pro forma CET-1, is not urgent if growth moderates; DTA and stored capital (Security Receipts) provide near-term levers. Bear case: Sequential momentum collapsed. QoQ PAT growth of 1.1% despite revenue +7.4% signals that NIM compression is outpacing growth—a structural headwind. NIM at 2.6% remains far below the 3%+ target; margin recovery is contingent on execution (RIDF deployment, repo benefit, repricing) and market forces (spread dynamics, competitive deposit intensity). Deposit competition is unrelenting; the 19.5% YoY deposit growth is skewed toward high-cost FCNR (₹18.5k Cr) and corporate term deposits. Capital is genuinely tight: 11.4% pro forma CET-1 leaves little room for unexpected stress or growth acceleration. At 17% YoY loan growth, the bank burns capital; a raise or growth moderation is imminent. AT-1 uncertainty (coupon payment status, judgment remedies) adds regulatory risk. Analysts pressed hard on capital, coupon mechanics, and margin timing; management deferred specifics pending assessment—appropriate caution, but a signal of uncertainty. Honest read: YES Bank is in a solid operational groove—loan growth, asset quality, cost discipline are real—but margin recovery is execution-dependent and capital is the limiting factor. H2 FY27 is the inflection quarter; if RIDF rundown and deposit repricing deliver 25–50bps NIM expansion (management's range), sequential PAT growth should re-accelerate. If spreads compress further or FCNR deployment stalls, the 2.6% NIM becomes the new norm, and capital constraints force growth moderation or a raise. A Hold, pending margin trajectory confirmation in Q3.

The bull–bear ledger

Loan growth 17.1% YoY beats 15–17% guidance; outpacing sector
Asset quality improving: Gross NPA 1.2%, Net 0.2%, slippages stable
Operating leverage visible: Cost-to-Income 64.3%, improved 290bps YoY from 67.1%
Deposit franchise scaling: +19.5% YoY, retail mix 58.8% (+20.9% YoY), CASA +15.5%
ROA progressing toward 1% target (Q2: 0.9%)
Sequential PAT growth stalled at 1.1% QoQ; margin headwinds outpacing growth
NIM compression 12–14bps to 2.6%; target 3%+ remains distant
Capital tight: Pro forma CET-1 11.4% (below peer comfort 12%+); raise deferred
AT-1 write-down creates ₹8.4k Cr capital hit and regulatory uncertainty
Deposit competition intense; FCNR & short-term wholesale high-cost
Margin recovery roadmap specific (RIDF ₹8k Cr H2, repo 25bps, repricing) but execution-dependent

Risks, ranked by severity to a holder

Capital constraint & AT-1 overhang

High

Pro forma CET-1 11.4% leaves limited headroom for 15–17% loan growth. AT-1 judgment reduces CET-1 by 240bps; capital raise deferred pending legal assessment. If growth continues at 17%, bank will need to raise capital or moderate lending by end of FY27. Regulatory pressure likely if CET-1 <12%.

NIM recovery execution

High

Margin path hinges on RIDF rundown (₹8k Cr H2), repo hike benefit (25bps), and deposit repricing (Nov+). Market spreads & competitive intensity could offset these tailwinds. If NIM stays at 2.6% or compresses further, sequential profit growth remains stalled and target 3%+ recedes.

Sequential profit momentum stalled

Medium

QoQ PAT growth 1.1% despite revenue +7.4% signals NIM headwinds outpacing growth. If this pattern continues into Q3, investor confidence erodes despite strong YoY figures. Q3/Q4 FY27 are critical to re-prove growth credibility.

FCNR deployment & credit risk concentration

Medium

₹18.5k Cr FCNR mobilized in Q2; deployment into loans expected Q3/Q4. Timing and yield uncertain. If deployment stalls (lack of credit appetite, rate environment), liquidity costs persist and NIM remains pressured.

Deposit competition & liability costs

Medium

19.5% YoY deposit growth is high-cost (FCNR ₹18.5k Cr, corporate term deposits high). Repricing power constrained. If CASA or retail deposit growth decelerates and wholesale mix rises, liability cost inflation accelerates and NIM compression persists.

Coupon payment uncertainty on AT-1

Medium

AT-1 coupon payment status under assessment per information memorandum terms. Multiple analyst questions met with deferred answers. If bank suspends coupons (rare but possible post-judgment), it signals capital stress and pressures equity holders.

What to watch next

1 · Q3 FY27: RIDF rundown & FCNR deployment traction
₹4,500 Cr RIDF redemption budgeted Q3. If deployment begins (into loans or higher-yielding securities), and margin stabilizes or narrows by <5bps (rather than repeating 12–14bps), management's roadmap gains credibility. Sequential PAT growth should re-accelerate if NIM trajectory inflects.
2 · Capital raise decision & AT-1 assessment completion
Expected by FY27 close (Mar 2027). If CET-1 stays 15%, bank will announce a raise. Timing, quantum, and form (equity, AT-1, hybrid) will signal management's confidence and regulatory room. Deferred decision until assessment complete suggests uncertainty.
3 · Deposit repricing & repo rate pass-through (Nov onwards)
November repricing and 25bps repo hike benefit begin to flow. If realised in sequential NIM improvement in Q3/Q4, margin recovery narrative holds. If spreads compress further (competitive pressure), NIM may actually decline despite tailwinds.

How the street is positioned

The stock is pricing in deep distress. At ₹15.8 (as of Oct 23, 2026), the stock is 96.09% below its all-time high of ₹404. It trades below all key moving averages—SMA20 ₹19.77, SMA50 ₹21.54, SMA200 ₹21.66—in a bearish downtrend. RSI at 17.5 signals oversold conditions, typically a reversal point, but the fundamentals (capital, margin compression, sequential profit stall) support caution. The 52-week range is ₹15.65–₹25.78; the stock is near the lows, suggesting panic selling or heavy shorting. Volume trend is increasing, which could imply weak holders exiting or shorts adding positions ahead of Q3 guidance.

Institutional ownership is skewed toward foreign investors. FII held 46.12% in Q1 FY27 (most recent quarter filed), with a slight trimming of 30 basis points quarter-on-quarter (from 46.42% in Q4 FY26). DII, meanwhile, added 223 basis points, rising from 21.82% to 24.05%. This suggests foreign investors are cautiously reducing exposure while domestic investors are stepping in—a typical pattern when the stock is deeply discounted. Promoter ownership remains zero, a historical peculiarity for YES Bank. The mixed flow (FII trimming, DII adding) suggests conviction on neither side; the market is waiting for Q3 results to break the tie.

The valuation drawdown (96% from ATH, trading at 52-week lows) is severe. But so are the near-term headwinds: capital constraints, margin uncertainty, and sequential profit stall. The oversold RSI and below-SMA positioning could attract dip buyers, but they'll need to believe Q3 FY27 will show NIM inflection and sequential PAT re-acceleration. The street's verdict, in price, is that these are not givens. Watch for institutional flows post-Q3; if NIM improves and capital raise is announced, FII inflows could re-establish. Until then, the stock reflects doubt.

YES Bank delivered strong operational execution in Q2—loan growth beat guidance, asset quality improved, and scale inflection points were crossed. But the quarter masks a near-term margin stall: sequential profit growth collapsed to 1.1% as NIM compressed 12–14 basis points due to FCNR mobilization. Management has a specific roadmap for recovery (RIDF ₹8,000 Cr H2, repo hike 25bps, deposit repricing post-Nov), but execution is uncertain and market spreads are the wildcards. Capital is the second limiter: pro forma CET-1 at 11.4% is tight for 15–17% growth; a raise or growth moderation looms by FY27 end. The AT-1 write-down, while manageable pro forma, adds regulatory uncertainty.

This is not a step-change quarter; it is steady execution with near-term headwinds. The debate hinges on whether Q3/Q4 FY27 will deliver NIM expansion (the honest read: 25–50bps is credible if execution holds and spreads don't collapse further) and whether management announces a capital raise (likely, given the tight CET-1). The number to track from here is sequential NIM in Q3 FY27—if it stabilizes or expands (rather than compressing further), the margin recovery story gains traction and sequential profit growth re-accelerates. Until then, the stock's deep discount reflects legitimate near-term uncertainty. A Hold, with upside if margins inflect and downside if capital pressures force growth moderation.

Informational and educational content only. Not investment advice.